Repository logo

Browsing by Author "Silva, DR"

Now showing 1 - 1 of 1
  • Clinical Standards for Diagnosis, Treatment and Prevention of Post-COVID-19 Lung Disease
    Publication . Visca, D; Centis, R; Pontali, E; Zampogna, E; Russell, AM; Migliori, GB; Andrejak, C; Aro, M; Bayram, H; Berkani, K; Bruchfeld, J; Chakaya, JM; Chorostowska-Wynimko, J; Crestani, B; Dalcolmo, MP; D’Ambrosio, L; Dinh-Xuan, AT; Duong-Quy, S; Fernandes, C; García-García, JM; de Melo Kawassaki, A; Carrozzi, L; Martinez-Garcia, MA; Carreiro Martins, P; Mirsaeidi, M; Mohammad, Y; Naidoo, RN; Neuparth, N; Sese, L; Silva, DR; Solovic, I; Sooronbaev, TM; Spanevello, A; Sverzellati, N; Tanno, L; Tiberi, S; Vasankari, T; Vasarmidi, E; Vitacca, M; Annesi-Maesano, I
    BACKGROUND: The aim of these clinical standards is to provide guidance on 'best practice' care for the diagnosis, treatment and prevention of post-COVID-19 lung disease.METHODS: A panel of international experts representing scientific societies, associations and groups active in post-COVID-19 lung disease was identified; 45 completed a Delphi process. A 5-point Likert scale indicated level of agreement with the draft standards. The final version was approved by consensus (with 100% agreement).RESULTS: Four clinical standards were agreed for patients with a previous history of COVID-19: Standard 1, Patients with sequelae not explained by an alternative diagnosis should be evaluated for possible post-COVID-19 lung disease; Standard 2, Patients with lung function impairment, reduced exercise tolerance, reduced quality of life (QoL) or other relevant signs or ongoing symptoms ≥4 weeks after the onset of first symptoms should be evaluated for treatment and pulmonary rehabilitation (PR); Standard 3, The PR programme should be based on feasibility, effectiveness and cost-effectiveness criteria, organised according to local health services and tailored to an individual patient's needs; and Standard 4, Each patient undergoing and completing PR should be evaluated to determine its effectiveness and have access to a counselling/health education session.CONCLUSION: This is the first consensus-based set of clinical standards for the diagnosis, treatment and prevention of post-COVID-19 lung disease. Our aim is to improve patient care and QoL by guiding clinicians, programme managers and public health officers in planning and implementing a PR programme to manage post-COVID-19 lung disease.
    2023Journal article Open access Show more